Biological detection method for Chinese medicine composition

一种检测方法、组合物的技术,应用在医药领域,能够解决不能体现整体药效等问题

Inactive Publication Date: 2019-05-28
SHIJIAZHUANG YILING PHARMA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For traditional Chinese medicine, the vast majority of clinical applications are traditional Chinese medicine compound prescriptions, and there are few cases where a single medicinal flavor is used. Its complex components and various pharmacological effects determine that the detection of one or several active ingredients cannot reflect its overall efficacy. , it is not feasible to evaluate traditional Chinese medicine only by this standard

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0162] Prescription: 255g forsythia, 255g honeysuckle, 85g roasted ephedra, 85g fried bitter almond, 255g gypsum, 255g isatis root, 255g Mianma Guanzhong, 255g houttuynia cordata, 85g patchouli, 51g rhubarb, 85g rhodiola, mint Brain 7.5g, licorice 85g;

[0163]Preparation method: the above thirteen flavors, patchouli plus water distillation to extract the volatile oil, collect the volatile oil, filter the water extract, and set aside; forsythia, ephedra, houttuynia, rhubarb are extracted twice with 70% ethanol, the first time 2 1.5 hours for the second time, filter the extract, combine, recover ethanol, and set aside; add honeysuckle, gypsum, isatis root, Mianma Guanzhong, licorice, and rhodiola to boiling, add fried bitter almonds, and cook for two 1.5 hours for the first time, 1 hour for the second time, filter the decoction, combine the filtrates, add the aqueous solution after patchouli oil extraction, concentrate to a relative density of 1.10-1.15 (60°C), add ethanol to m...

Embodiment 2

[0169] Bioassay method:

[0170] Step a, establishment of inflammation model: RAW264.7 cells in the logarithmic growth phase were digested with 0.25% trypsin, and the cell concentration was adjusted to 1×10 4 cells / well, seeded in 96-well plate, placed in 5% CO 2 , Cultivate in a 37°C incubator for 24 hours, discard the supernatant, wash twice with PBS, add 200 μL normal medium to the blank well, add 200 μL LPS medium with a final concentration of 1.0 μg / mL and a final concentration of 200 ng / mL to the model well IFN-γ medium, the drug group was given a certain concentration of traditional Chinese medicine composition under the inflammation model, placed in 5% CO 2 , Cultivate in a 37°C incubator for 24 hours. Aspirate the cell supernatant for the determination of the expression level of IL-6 secreted by the cells;

[0171] Step b, measuring the concentration of the inflammatory factor IL-6 in the cells: measuring the content of IL-6 in the cell supernatant by an immunoradi...

Embodiment 3

[0174] Bioassay method:

[0175] Step a, establishment of inflammation model: RAW264.7 cells in the logarithmic growth phase were digested with 0.25% trypsin, and the cell concentration was adjusted to 1×10 4 cells / well, seeded in 96-well plate, placed in 5% CO 2 , Cultivate in a 37°C incubator for 24 hours, discard the supernatant, wash twice with PBS, add 200 μL normal medium to the blank well, add 200 μL LPS medium with a final concentration of 1.0 μg / mL and a final concentration of 200 ng / mL to the model well IFN-γ medium, the drug group was given a certain concentration of traditional Chinese medicine composition under the inflammation model, placed in 5% CO 2 , Cultivate in a 37°C incubator for 24 hours. Aspirate the cell supernatant for the determination of the expression level of IL-6 secreted by the cells;

[0176] Step b, measuring the concentration of the inflammatory factor IL-6 in the cells: measuring the content of IL-6 in the cell supernatant by PCR method, a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a biological detection method for a Chinese medicine composition. With inhibition of the Chinese medicine composition on an inflammatory factor IL-6 being a determining index,the method detects the anti-inflammation activity of the Chinese medicine composition. The method includes the steps that A, a Chinese medicine composition sample solution and a comparison product solution are prepared; B, the inhibition rates of the sample solution and the comparison product solution on the inflammatory factor IL-6 are determined; C, with the inhibition rates on the inflammatoryfactor IL-6 being indexes, the valence and the confidence limit rate are calculated.

Description

technical field [0001] The invention relates to a biological detection method of a traditional Chinese medicine composition, belonging to the field of medicine. Background technique [0002] At present, the quality evaluation of traditional Chinese medicine compound is only carried out by measuring a single chemical component. First, whether the chemical component is the substance that exerts the medicinal effect of the compound. Second, whether controlling the minimum content of the chemical component can effectively control the effectiveness and quality of its quality. consistency. Judging from the current research, it is obviously impossible to evaluate the quality of traditional Chinese medicine compound only by measuring a single chemical component. Therefore, according to the specific situation of Chinese medicine compound prescriptions, combined with modern science and technology, how to explore the quality evaluation and control methods of Chinese medicine compound ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/50
CPCA61K36/78C12Q1/6844G01N33/15G01N33/50G01N33/53
Inventor 肖小河王伽伯贾振华张海珠牛明马永刚王宏涛田书彦
Owner SHIJIAZHUANG YILING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products